The global DNA microarray market size was valued at USD 2.28 billion in 2023 and is projected to reach around USD 5.04 billion by 2032, representing a CAGR of 9.20% from 2023 to 2032.
The DNA microarray market is a dynamic sector characterized by the utilization of advanced genomic technologies. This market revolves around the analysis of multiple genes within a biological sample, enabling researchers and clinicians to understand gene expression patterns comprehensively. DNA microarrays play a pivotal role in genomics research, diagnostics, and personalized medicine, offering a high-throughput method for studying the expression of thousands of genes simultaneously.
Key Takeaways
- North America led the global market with the highest market share of 36% in 2022.
- Asia-Pacific is expected to expand at the fastest CAGR during the forecast period.
- By type, the oligonucleotide DNA microarrays segment had a major market revenue share of 45% in 2022.
- By type, the complementary DNA microarrays segment is anticipated to grow a noteworthy CAGR of 10.1% during the projected period.
- By application, the gene expression analysis segment contributed more than 46% of revenue share in 2022.
- By end-user, the academic & research institutes segment has held the major market share of 37% in 2022.
- By end-user, the diagnostic centers segment is predicted to grow at the fastest CAGR over the projected period.
Growth Factors
The DNA Microarray market experiences robust growth due to the escalating demand for personalized medicine and the increasing prevalence of genetic disorders. Technological advancements in microarray technologies, such as enhanced sensitivity and accuracy, are driving market expansion. Additionally, the growing focus on precision medicine and the surge in research activities in fields like oncology and pharmacogenomics contribute significantly to the market’s upward trajectory.
Regions Snapshot
The market exhibits a global presence, with North America, Europe, Asia-Pacific, and the rest of the world being key regions. North America, particularly the United States, dominates the market owing to well-established healthcare infrastructure, substantial investments in research and development, and a high prevalence of genetic disorders. Asia-Pacific is emerging as a lucrative market, propelled by increasing awareness, rising healthcare expenditure, and a growing emphasis on genomics research.
Get a Sample: https://www.precedenceresearch.com/sample/3648
DNA Microarray Market Scope
| Report Coverage | Details |
| Growth Rate from 2023 to 2032 | CAGR of 9.20% |
| Market Size in 2023 | USD 2.28 Billion |
| Market Size by 2032 | USD 5.04 Billion |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Type, By Application, and By End-user |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read Also: Web 3.0 Market Size To Rake USD 65.78 Bn By 2032
DNA Microarray Market Dynamics
Drivers:
Key drivers of the DNA Microarray market include the continuous advancements in genomic research, rising government initiatives to promote genomics and personalized medicine, and the expanding application scope in various therapeutic areas. Additionally, the increasing adoption of DNA microarray technologies in clinical diagnostics and drug discovery processes fuels market growth.
Opportunities:
Opportunities in the DNA Microarray market lie in untapped emerging markets, collaborative efforts between industry players and research institutions, and the development of cost-effective and user-friendly microarray technologies. The integration of artificial intelligence and machine learning in data analysis presents a promising avenue for market players to explore and enhance the efficiency of microarray-based studies.
Challenges:
Despite the positive outlook, the DNA Microarray market faces challenges related to data standardization, ethical concerns surrounding genetic information, and the high cost of advanced microarray technologies. Additionally, the complexity of data interpretation and the need for skilled professionals pose challenges to widespread adoption.
Reasons to Purchase this Report:
- Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
- In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
- Market size in USD million and volume in million units provided for each segment and sub-segment.
- Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
- Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.
Recent Developments
- In 2020, Thermo Fisher Scientific Inc. partnered with QIAGEN N.V. to expand its offering of molecular diagnostics solutions, including DNA microarrays.
- In 2018, Agilent announced a strategic scientific collaboration with the University of Southern California (USC) to support innovative biomedical science and engineering research initiatives, fostering transformational advancements in these fields.
- In 2017, Bio-Rad Laboratories, Inc. acquired RainDance Technologies, Inc., a company specializing in droplet-based microfluidics solutions for genomics research, complementing its microarray offerings.
DNA Microarray Market Companies
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Illumina, Inc.
- PerkinElmer, Inc.
- Bio-Rad Laboratories, Inc.
- Roche Diagnostics
- Qiagen N.V.
- Oxford Gene Technology (OGT)
- Applied Microarrays, Inc.
- Eurofins Genomics LLC
- LC Sciences
- Microarrays Inc.
- Arrayit Corporation
- BioCat GmbH
- Savyon Diagnostics Ltd.
Segments Covered in the Report
By Type
- Complementary DNA Microarrays
- Oligonucleotide DNA Microarrays
- Others
By Application
- Gene Expression Analysis
- Genotyping
- Others
By End-user
- Pharmaceutical and Biotechnology Companies
- Diagnostic Centers
- Hospitals and Clinics
- Academic and Research Institute
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on DNA Microarray Market
5.1. COVID-19 Landscape: DNA Microarray Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global DNA Microarray Market, By Type
8.1. DNA Microarray Market, by Type, 2023-2032
8.1.1 Complementary DNA Microarrays
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Oligonucleotide DNA Microarrays
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global DNA Microarray Market, By Application
9.1. DNA Microarray Market, by Application, 2023-2032
9.1.1. Gene Expression Analysis
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Genotyping
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global DNA Microarray Market, By End-user
10.1. DNA Microarray Market, by End-user, 2023-2032
10.1.1. Pharmaceutical and Biotechnology Companies
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Diagnostic Centers
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Hospitals and Clinics
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Academic and Research Institute
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global DNA Microarray Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2020-2032)
11.1.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.3. Market Revenue and Forecast, by End-user (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Type (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.4.3. Market Revenue and Forecast, by End-user (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Type (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.5.3. Market Revenue and Forecast, by End-user (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2020-2032)
11.2.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.3. Market Revenue and Forecast, by End-user (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Type (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.4.3. Market Revenue and Forecast, by End-user (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Type (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.5.3. Market Revenue and Forecast, by End-user (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Type (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.6.3. Market Revenue and Forecast, by End-user (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Type (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.7.3. Market Revenue and Forecast, by End-user (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2020-2032)
11.3.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.3. Market Revenue and Forecast, by End-user (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Type (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.4.3. Market Revenue and Forecast, by End-user (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Type (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.5.3. Market Revenue and Forecast, by End-user (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Type (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.6.3. Market Revenue and Forecast, by End-user (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Type (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.7.3. Market Revenue and Forecast, by End-user (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2020-2032)
11.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.3. Market Revenue and Forecast, by End-user (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Type (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.4.3. Market Revenue and Forecast, by End-user (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Type (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.5.3. Market Revenue and Forecast, by End-user (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Type (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.6.3. Market Revenue and Forecast, by End-user (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Type (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.7.3. Market Revenue and Forecast, by End-user (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2020-2032)
11.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.3. Market Revenue and Forecast, by End-user (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Type (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.4.3. Market Revenue and Forecast, by End-user (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Type (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.5.3. Market Revenue and Forecast, by End-user (2020-2032)
Chapter 12. Company Profiles
12.1. Thermo Fisher Scientific Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Agilent Technologies, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Illumina, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. PerkinElmer, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Bio-Rad Laboratories, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Roche Diagnostics
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Qiagen N.V.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Oxford Gene Technology (OGT)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Applied Microarrays, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Eurofins Genomics LLC
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/